Publications of W. Zieglgänsberger
All genres
Journal Article (166)
21.
Journal Article
134 (Suppl. 4), pp. S127 - S131 (2009)
Schmerzverarbeitung, Schmerzgedächtnis und Schlafqualität. Deutsche Medizinische Wochenschrift 22.
Journal Article
4 (6), doi: 10.1371/journal.pone.0005785 (2009)
Resolution of Ultramicroscopy and Field of View Analysis. PLoS ONE 23.
Journal Article
56 (3), pp. 626 - 636 (2009)
Isoflurane anaesthesia reversibly improves cognitive function and long-term potentiation (LTP) via an up-regulation in NMDA receptor 2B subunit expression. Neuropharmacology 24.
Journal Article
13 (2), pp. 124 - 129 (2009)
Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse. European Journal of Pain 25.
Journal Article
22 (5), pp. 594 - 603 (2008)
Risikoabschätzung in der Schmerztherapie. Schmerz 26.
Journal Article
105 (34), pp. 12539 - 12544 (2008)
The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons. Proceedings of the National Academy of Sciences of the United States of America 27.
Journal Article
115 (8), pp. 1119 - 1126 (2008)
The fraction of activated N-methyl-D-aspartate receptors during synaptic transmission remains constant in the presence of the glutamate release inhibitor riluzole. Journal of Neural Transmission 28.
Journal Article
20 (Suppl. 1), p. 43 - 43 (2008)
Current aspects of pain management - pain therapy defined by neuro-psychological mechanisms. Acta Neuropsychiatrica 29.
Journal Article
15 (3), pp. 143 - 152 (2008)
Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learning & Memory 30.
Journal Article
14 (2), pp. 107 - 119 (2008)
Tolperisone: A typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neuroscience & Therapeutics 31.
Journal Article
40 (5), p. 247 - 247 (2007)
Functional Consequences of the accumulation of psychopharmacological drugs in "lipid rafts" on ligand-gated ion channels. Pharmacopsychiatry 32.
Journal Article
416 (1), pp. 82 - 86 (2007)
Corticotropin-releasing factor (CRF) receptor type 1-dependent modulation of synaptic plasticity. Neuroscience Letters 33.
Journal Article
4 (4), pp. 331 - 336 (2007)
Ultramicroscopy: three-dimensional visualization of neuronal networks in the whole mouse brain. Nature Methods 34.
Journal Article
27 (4), pp. 832 - 839 (2007)
Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. The Journal of Neuroscience 35.
Journal Article
52, pp. 716 - 723 (2007)
Nitrous oxide (N2O) pre- and postsynaptically attenuates NMDA receptor-mediated neurotransmission in the amygdala. Neuropharmacology 36.
Journal Article
26 (21), pp. 5794 - 5799 (2006)
Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 37.
Journal Article
51, pp. 455 - 466 (2006)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 38.
Journal Article
25 (44), pp. 10198 - 10206 (2005)
Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains. The Journal of Neuroscience 39.
Journal Article
16 (9), pp. 993 - 996 (2005)
WIN 55,212-2 decreases the spatial spread of neocortical excitation in vitro. NeuroReport 40.
Journal Article
10 (4), pp. 298 - 308 (2005)
Understanding neuropathic pain. CNS Spectrums